Solid Lipid Nanoparticle Formulations. Pharmacokinetic and Biopharmaceutical Aspects in Drug Delivery

Methods in Enzymology

Volumn 464, Issue C, 2009, Pages 105-129

  Souto, Eliana B ^a,b   Doktorovová, Slavomira ^a  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; BUTYRIC ACID; CALCITONIN; CAMPTOTHECIN; CLOZAPINE; CYCLOSPORIN A; DICLOFENAC; FENOFIBRATE; FLUOROURACIL; FLURBIPROFEN; GLYCEROL STEARATE; IBUPROFEN; INSULIN; ISOTRETINOIN; MACROGOL; MEVINOLIN; MITOXANTRONE; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PENCICLOVIR; PHOSPHATIDYLCHOLINE; PODOPHYLLOTOXIN; POLOXAMER; PSORALEN; SALCATONIN; SOLID LIPID NANOPARTICLE; TEMOZOLOMIDE; UNINDEXED DRUG; VINPOCETINE; LIPID; NANOPARTICLE;

CARDIOTOXICITY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NEPHROTOXICITY; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING; ARTICLE; CHEMISTRY;

CHEMISTRY, PHARMACEUTICAL; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; LIPIDS; NANOPARTICLES;

EID: 71549167988     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)64006-4     Document Type: Review

References (134)

1. Abdelbary G., and Fahmy R.H. Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech 10 (2009) 211-219
2. Asasutjarit R., Lorenzen S.I., Sirivichayakul S., Ruxrungtham K., Ruktanonchai U., and Ritthidej G.C. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro type pHIS-HIV-Hugag transfection. Pharm. Res. 24 (2007) 1098-1107
3. Attama A.A., Reichl S., and Müller-Goymann C.C. Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int. J. Pharm. 355 (2008) 307-313
4. Battaglia L., Trotta M., Gallarate M., Carlotti M.E., Zara G.P., and Bargoni A. Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability. J. Microencapsul. 24 (2007) 660-672
5. Bhaskar K., Anbu J., Ravichandiran V., Venkateswarlu V., and Rao Y.M. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 8 (2009) 6
6. Bhaskar K., Krishna Mohan C., Lingam M., Jagan Mohan S., Venkateswarlu V., Madhusudan Rao Y., Anbu J., and Ravichandran V. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: In vitro and in vivo characteristics. Drug Dev. Ind. Pharm. 35 (2009) 98-113
7. Bi R., Shao W., Wang Q., and Zhang N. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. J. Biomed. Nanotechnol. 5 (2009) 84-92
8. Bondi M.L., Azzolina A., Craparo E.F., Capuano G., Lampiasi N., Giammona G., and Cervello M. Solid lipid nanoparticles containing nimesulide: Preparation, characterization and cytotoxicity studies. Curr. Nanosci. 5 (2009) 39-44
9. Bondi M.L., Montana G., Craparo E.F., Picone P., Capuano G., Carlo M.D., and Giammona G. Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimers disease: Preparation, characterization and cytotoxicity studies. Curr. Nanosci. 5 (2009) 26-32
10. Brioschi A., Zenga F., Zara G.P., Gasco M.R., Ducati A., and Mauro A. Solid lipid nanoparticles: Could they help to improve the efficacy of pharmacologic treatments for brain tumors?. Neurol. Res. 29 (2007) 324-330
11. Brioschi A., Zara G.P., Calderoni S., Gasco M.R., and Mauro A. Cholesteryl butyrate solid lipid nanoparticles as a butyric acid prodrug. Molecules 13 (2008) 230-254
12. Bunjes H., and Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv. Drug Deliv. Rev. 59 (2007) 379-402
13. Casadei M.A., Cerreto F., Cesa S., Giannuzzo M., Feeney M., Marianecci C., and Paolicelli P. Solid lipid nanoparticles incorporated in dextran hydrogels: A new drug delivery system for oral formulations. Int. J. Pharm. 325 (2006) 140-146
14. Castro G.A., Orefice R.L., Vilela J.M., Andrade M.S., and Ferreira L.A. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J. Microencapsul. 24 (2007) 395-407
15. Cengiz E., Wissing S.A., Müller R.H., and Yazan Y. Sunblocking efficiency of various TiO(2)-loaded solid lipid nanoparticle formulations(1). Int. J. Cosmet. Sci. 28 (2006) 371-378
16. Chattopadhyay N., Zastre J., Wong H.L., Wu X.Y., and Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm. Res. 25 (2008) 2262-2271
17. Chen H.B., Chang X.L., Du D.R., Liu W., Liu J., Weng T., Yang Y.J., Xu H.B., and Yang X.L. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release 110 (2006) 296-306
18. de Ven H.V., Vermeersch M., Shunmugaperumal T., Vandervoort J., Maes L., and Ludwig A. Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins. Pharmazie 64 (2009) 172-176
19. des Rieux A., Fievez V., Garinot M., Schneider Y.-J., and Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Control. Release 116 (2006) 1-27
20. Dianzani C., Cavalli R., Zara G.P., Gallicchio M., Lombardi G., Gasco M.R., Panzanelli P., and Fantozzi R. Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells. Br. J. Pharmacol. 148 (2006) 648-656
21. Dong X., Mattingly C.A., Tseng M., Cho M., Adams V.R., and Mumper R.J. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur. J. Pharm. Biopharm. 72 (2008) 9-17
22. El Assawy N., Priano L., Gasco M., and Mauro A. Baclofen-loaded solid lipid nanoparticles administration in rats: Pharmacokinetics and neurophysiological study. 18th Meeting of the European Neurological Society, Nice, France (2008) P259
23. Esposito E., Fantin M., Marti M., Drechsler M., Paccamiccio L., Mariani P., Sivieri E., Lain F., Menegatti E., Morari M., and Cortesi R. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25 (2008) 1521-1530
24. Faisal S., Baboota S., Ali J., and Ahuja A. Development and characterization of carvedilol-loaded solid lipid nanoparticles. J. Pharm. Pharmacol. 60 (2008) 150
25. Fang J.Y., Fang C.L., Liu C.H., and Su Y.H. Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 70 (2008) 633-640
26. Fundaro A., Cavalli R., Bargoni A., Vighetto D., Zara G.P., and Gasco M.R. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol. Res. 42 (2000) 337-343
27. Gallarate M., Trotta M., Battaglia L., and Chirio D. Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation. J. Microencapsul. (2008) 1-9
28. Gokce E.H., Sandri G., Bonferoni M.C., Rossi S., Ferrari F., Guneri T., and Caramella C. Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity. Int. J. Pharm. 364 (2008) 76-86
29. Han F., Li S.M., Yin R., Shi X.L., and Jai Q. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen. Drug Dev. Ind. Pharm. 34 (2008) 453-458
30. Han C., Qi C.M., Zhao B.K., Cao J., Xie S.Y., Wang S.L., and Zhou W.Z. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: In vitro and in vivo studies. J. Vet. Pharmacol. Ther. 32 (2009) 116-123
31. Hanafy A., Spahn-Langguth H., Vergnault G., Grenier P., Tubic Grozdanis M., Lenhardt T., and Langguth P. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv. Drug Deliv. Rev. 59 (2007) 419-426
32. Hentschel A., Gramdorf S., Müller R.H., and Kurz T. Beta-carotene-loaded nanostructured lipid carriers. J. Food Sci. 73 (2008) N1-N6
33. Hsu M.H., and Su Y.C. Iron-oxide embedded solid lipid nanoparticles for magnetically controlled heating and drug delivery. Biomed. Microdevices 10 (2008) 785-793
34. Hu F.-Q., Jiang S.-P., Du Y.-Z., Yuan H., Ye Y.-Q., and Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 314 (2006) 83-89
35. Huang G., Zhang N., Bi X., and Dou M. Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity. Int. J. Pharm. 355 (2008) 314-320
36. Huang Z.-r., Hua S.-c., Yang Y.-l., and Fang J.-y. Development and evaluation of lipid nanoparticles for camptothecin delivery: A comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin. 29 (2008) 1094-1102
37. Iscan Y., Hekimoglu S., Sargon M.F., and Hincal A.A. DEET-loaded solid lipid particles for skin delivery: In vitro release and skin permeation characteristics in different vehicles. J. Microencapsul. 23 (2006) 315-327
38. Jain D., and Banerjee R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J. Biomed. Mater. Res. Part B Appl. Biomater. 86B (2008) 105-112
39. Jain S.K., Chaurasiya A., Gupta Y., Jain A., Dagur P., Joshi B., and Katoch V.M. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. J. Microencapsul. 25 (2008) 289-297
40. Jee J.P., Lim S.J., Park J.S., and Kim C.K. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 63 (2006) 134-139
41. Johnsson M., Lam Y., Barauskas J., and Tiberg F. Aqueous phase behavior and dispersed nanoparticles of diglycerol monooleate/glycerol dioleate mixtures. Langmuir 21 (2005) 5159-5165
42. Joshi M., and Patravale V. Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib. Drug Dev. Ind. Pharm. 32 (2006) 911-918
43. Joshi M., and Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm. 346 (2008) 124-132
44. Joshi M., Pathak S., Sharma S., and Patravale V. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. Int. J. Pharm. 364 (2008) 119-126
45. Kuchler S., Radowski M.R., Blaschke T., Dathe M., Plendl J., Haag R., Schafer-Korting M., and Kramer K.D. Nanoparticles for skin penetration enhancement-A comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 71 (2009) 243-250
46. Kumar V.V., Chandrasekar D., Ramakrishna S., Kishan V., Rao Y.M., and Diwan P.V. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics. Int. J. Pharm. 335 (2007) 167-175
47. Kuntsche J., Koch M.H., Drechsler M., and Bunjes H. Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers. Colloids Surf. B Biointerfaces 44 (2005) 25-35
48. Kuo Y.C., and Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 365 (2009) 206-213
49. Kuo Y.C., and Su F.L. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 340 (2007) 143-152
50. Lee G.S., Lee D.H., Kang K.C., Lee C.I., Pyo H.B., and Choi T.B. Preparation and characterization of bis-ethylhexyloxyphenolmethoxyphenyltriazine (BEMT) loaded solid lipid nano-particles (SLN). J. Ind. Eng. Chem. 13 (2007) 1180-1187
51. Lee M.K., Lim S.J., and Kim C.K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28 (2007) 2137-2146
52. Li X., Nie S.F., Kong J., Li N., Ju C.Y., and Pan W.S. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int. J. Pharm. 363 (2008) 177-182
53. Li H.L., Zhao X.B., Ma Y.K., Zhai G.X., Li L.B., and Lou H.X. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 133 (2009) 238-244
54. Lian J., Zhang S., Wang J., Fang K., Zhang Y., and Hao Y. Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate. J. Drug Target. 16 (2008) 250-256
55. Liu J., Hu W., Chen H.B., Ni Q., Xu H.B., and Yang X.L. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328 (2007) 191-195
56. Liu J., Hu W., Chen H., Ni Q., Xu H., and Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328 (2007) 191-195
57. Liu H., Gong T., Fu H.L., Wang C.G., Wang X.L., Chen Q., Zhang Q., He Q., and Zhang Z.R. Solid lipid nanoparticles for pulmonary delivery of insulin. Int. J. Pharm. 356 (2008) 333-344
58. Liu J., Gong T., Fu H., Wang C., Wang X., Chen Q., Zhang Q., He Q., and Zhang Z. Solid lipid nanoparticles for pulmonary delivery of insulin. Int. J. Pharm. 356 (2008) 333-344
59. Liu K., Sun J., Wang Y.J., He Y., Gao K., and He Z.G. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers. Drug Dev. Ind. Pharm. 34 (2008) 465-471
60. Liu W., Hu M., Xue C., Xu H., and Yang X. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int. J. Pharm. 364 (2008) 135-141
61. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Röder B., Kramer K.D., and Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 110 (2005) 151-163
62. Lu B., Xiong S.B., Yang H., Yin X.D., and Chao R.B. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur. J. Pharm. Sci. 28 (2006) 86-95
63. Lu B., Xiong S.B., Yang H., Yin X.D., and Chao R.B. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur. J. Pharm. Sci. 28 (2006) 86-95
64. Lu X., Howard M.D., Mazik M., Eldridge J., Rinehart J.J., Jay M., and Leggas M. Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: Optimization and in vitro characterization. AAPS J. 10 (2008) 133-140
65. Luo Y., Chen D.W., Ren L.X., Zhao X.L., and Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 114 (2006) 53-59
66. Lv Q., Yu A., Xi Y., Li H., Song Z., Cui J., Cao F., and Zhai G. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm. 372 (2009) 191-198
67. Mandawgade S.D., and Patravale V.B. Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int. J. Pharm. 363 (2008) 132-138
68. Manjunath K., and Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Control. Release 107 (2005) 215-228
69. Manjunath K., and Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Drug Target. 14 (2006) 632-645
70. Martins S., Sarmento B., Souto E.B., and Ferreira D.C. Insulin-loaded alginate microspheres for oral delivery-Effect of polysaccharide reinforcement on physicochemical properties and release profile. Carbohydr. Polym. 69 (2007) 725-731
71. Martins S., Silva A.C., Ferreira D.C., and Souto E.B. Improving oral absorption of samon calcitonin by trimyristin lipid nanoparticles. J. Biomed. Nanotechnol. 5 (2009) 76-83
72. Müller R.H., Rühl D., and Runge S.A. Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int. J. Pharm. 144 (1996) 115-121
73. Müller R.H., Radtke M., and Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (2002) S131-S155
74. Müller R.H., Runge S., Ravelli V., Mehnert W., Thünemann A.F., and Souto E.B. Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int. J. Pharm. 317 (2006) 82-89
75. Müller R.H., Petersen R.D., Hommoss A., and Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev. 59 (2007) 522-530
76. Müller R.H., Runge S.A., Ravelli V., Thunemann A.F., Mehnert W., and Souto E.B. Cyclosporine-loaded solid lipid nanoparticles (SLN): Drug-lipid physicochemical interactions and characterization of drug incorporation. Eur. J. Pharm. Biopharm. 68 (2008) 535-544
77. Olbrich C., Kayser O., and Müller R.H. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-Effect of surfactants, storage time and crystallinity. Int. J. Pharm. 237 (2002) 119-128
78. Paliwal R., Rai S., Vaidya B., Khatri K., Goyal A.K., Mishra N., Mehta A., and Vyas S.P. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 5 (2008) 184-191
79. Paolicelli P., Cerreto F., Cesa S., Feeney M., Corrente F., Marianecci C., and Casadei M.A. Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs. J. Microencapsul. (2008) 1-10
80. Pardeike J., Hommoss A., and Müller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366 (2008) 170-184
81. Pojarova M., Ananchenko G.S., Udachin K.A., Daroszewska M., Perret F., Coleman A.W., and Ripmeester J.A. Solid lipid nanoparticles of p-hexanoyl calix[4]arene as a controlling agent in the photochemistry of a sunscreen blocker. Chem. Mater. 18 (2006) 5817-5819
82. Polovyanenko D.N., Bagryanskaya E.G., Schnegg A., Mobius K., Coleman A.W., Ananchenko G.S., Udachin K.A., and Ripmeester J.A. Inclusion of 4-methoxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl in a calixarene nanocapsule in the solid state. Phys. Chem. Chem. Phys. 10 (2008) 5299-5307
83. Pople P.V., and Singh K.K. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech 7 (2006) Article 91
84. Priano L., Esposti D., Esposti R., Castagna G., De Medici C., Fraschini F., Gasco M.R., and Mauro A. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J. Nanosci. Nanotechnol. 7 (2007) 3596-3601
85. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., and Ricci M. Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation. Int. J. Pharm. 357 (2008) 295-304
86. Reddy L.H., Adhikari J.S., Dwarakanath B.S.R., Sharma R.K., and Murthy R.R. Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice. AAPS J. 8 (2006) E254-E262
87. Rezzani R., Rodella L.F., Fraschini F., Gasco M.R., Demartini G., Musicanti C., and Reiter R.J. Melatonin delivery in solid lipid nanoparticles: Prevention of cyclosporine A induced cardiac damage. J. Pineal Res. 46 (2009) 255-261
88. Ruckmani K., Sivakumar M., and Ganeshkumar P.A. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. J. Nanosci. Nanotechnol. 6 (2006) 2991-2995
89. Ruckmani K., Sivakumar M., and Ganeshkumar P.A. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. International Conference on Nanotechnology in Advanced Drug Delivery, Nagar, India (2006) 2991-2995
90. Ruktanonchai U., Bejrapha P., Sakulkhu U., Opanasopit P., Bunyapraphatsara N., Junyaprasert V., and Puttipipatkhachorn S. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. AAPS PharmSciTech 10 (2009) 227-234
91. Sanjula B., Shah F.M., Javed A., and Alka A. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J. Drug Target. 17 (2009) 249-256
92. Sarmento B., Martins S., Ferreira D., and Souto E.B. Oral insulin delivery by means of solid lipid nanoparticles. Int. J. Nanomedicine 2 (2007) 743-749
93. Scalia S., and Mezzena M. Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. Drug Dev.Ind. Pharm. 35 (2009) 192-198
94. Serpe L., Guido M., Canaparo R., Muntoni E., Cavalli R., Panzanelli P., Della Pepal C., Bargoni A., Mauro A., Gasco M.R., Eandi M., and Zara G.P. Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines. J. Nanosci. Nanotechnol. 6 (2006) 3062-3069
95. Shah K.A., Date A.A., Joshi M.D., and Patravale V.B. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int. J. Pharm. 345 (2007) 163-171
96. Shahgaldian P., Sciotti M.A., and Pieles U. Amino-substituted amphiphilic calixarenes: Self-assembly and interactions with DNA. Langmuir 24 (2008) 8522-8526
97. Sharma P., Ganta S., Denny W.A., and Garg S. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil. Int. J. Pharm. 367 (2009) 187-194
98. Silva A.C., Santos D., Ferreira D.C., and Souto E.B. Minoxidil-loaded nanostructured lipid carriers (NLC): Characterization and rheological behaviour of topical formulations. Pharmazie 64 (2009) 177-182
99. Souto E.B., and Müller R.H. The use of SLN (R) and NLC (R) as topical particulate carriers for imidazole antifungal agents. Pharmazie 61 (2006) 431-437
100. Souto E.B., and Müller R.H. Lipid nanoparticles (SLN and NLC) for drug delivery. In: Domb A.J., Tabata Y., Ravi Kumar M.N.V., and Farber S. (Eds). Nanoparticles for Pharmaceutical Applications (2007), American Scientific Publishers, Los Angeles, California, USA 103-122
101. Souto E.B., and Müller R.H. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int. J. Cosmet. Sci. 30 (2008) 157-165
102. Souto E.B., Mehnert W., and Müller R.H. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J. Microencapsul. 23 (2006) 417-433
103. Souto E.B., Almeida A.J., and Müller R.H. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: Structure, protection and skin effects. J. Biomed. Nanotechnol. 3 (2007) 317-331
104. Stecova J., Mehnert W., Blaschke T., Kleuser B., Sivaramakrishnan R., Zouboulis C.C., Seltmann H., Korting H.C., Kramer K.D., and Schafer-Korting M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: Particle characterisation and skin uptake. Pharm. Res. 24 (2007) 991-1000
105. Suresh G., Manjunath K., Venkateswarlu V., and Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech 8 (2007) 24
106. Tausch C., Konstantiniuk P., Kugler F., Reitsamer R., Roka S., Postlberger S., and Haid A. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: Findings from the Austrian Sentinel Node Study Group. Ann. Surg. Oncol. 15 (2008) 3378-3383
107. Teeranachaideekul V., Müller R.H., and Junyaprasert V.B. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-Effects of formulation parameters on physicochemical stability. Int. J. Pharm. 340 (2007) 198-206
108. Teeranachaideekul V., Souto E.B., Junyaprasert V.B., and Müller R.H. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10)-Development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 67 (2007) 141-148
109. Teeranachaideekul V., Boonme P., Souto E.B., Müller R.H., and Junyaprasert V.B. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J. Control. Release 128 (2008) 134-141
110. Teeranachaideekul V., Souto E.B., Müller R.H., and Junyaprasert V.B. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels). J. Microencapsul. 25 (2008) 111-120
111. Teeranachaideekul V., Boonme P., Souto E.B., Müller R.H., and Junyaprasert V.B. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J. Control. Release 128 (2008) 134-141
112. Tian J., Pang X., Yu K., Liu L., and Zhou J. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin. Pharmazie 63 (2008) 593-597
113. Triplett M.D., and Rathman J.F. Optimization of beta-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. J. Nanopart. Res. 11 (2009) 601-614
114. Videira M.A., Botelho M.F., Santos A.C., Gouveia L.F., Pedroso De Lima J.J., and Almeida A.J. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target. 10 (2002) 607-613
115. Vivek K., Reddy H., and Murthy R.S. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 8 (2007) E83
116. Wang Y., and Wu W. In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages. Drug Deliv. 13 (2006) 189-192
117. Wang D., Zhao P., Cuia F., and Li X. Preparation and characterization of solid lipid nanoparticles loaded with total flavones of Hippophae rhamnoides (TFH). PDA J. Pharm. Sci. Technol. 61 (2007) 110-120
118. Wang J.J., Liu K.S., Sung K.C., Tsai C.Y., and Fang J.Y. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: Lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. J. Microencapsul. (2009) 1-14
119. Wissing S., and Müller R. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int. J. Pharm. 242 (2002) 377-379
120. Xia Q., Saupe A., Müller R.H., and Souto E.B. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int. J. Cosmet. Sci. 29 (2007) 473-482
121. Xiang Q.Y., Wang M.T., Chen F., Gong T., Jian Y.L., Zhang Z.R., and Huang Y. Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch. Pharm. Res. 30 (2007) 519-525
122. Xu Z., Chen L., Gu W., Gao Y., Lin L., Zhang Z., Xi Y., and Li Y. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 30 (2009) 226-232
123. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., and Yang C.Z. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Release 59 (1999) 299-307
124. Yang L., Geng Y., Li H., Zhang Y., You J., and Chang Y. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles. Pharmazie 64 (2009) 86-89
125. Ye J., Wang Q., Zhou X., and Zhang N. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int. J. Pharm. 352 (2008) 273-279
126. Ying X.Y., Du Y.Z., Chen W.W., Yuan H., and Hu F.Q. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release. Pharmazie 63 (2008) 878-882
127. Yuan H., Chen J., Du Y.-Z., Hu F.-Q., Zeng S., and Zhao H.-L. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf. B Biointerfaces 58 (2007) 157-164
128. Yuan H., Miao J., Du Y.Z., You J., Hu F.Q., and Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int. J. Pharm. 348 (2008) 137-145
129. Zara G.P., Bargoni A., Cavalli R., Fundaro A., Vighetto D., and Gasco M.R. Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J. Pharm. Sci. 91 (2002) 1324-1333
130. Zara G.P., Cavalli R., Bargoni A., Fundaro A., Vighetto D., and Gasco M.R. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues. J. Drug Target. 10 (2002) 327-335
131. Zhang J.Q., Liu J., Li Y.L., and Jasti B.R. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 14 (2007) 381-387
132. Zhang W., Liu J., Li S., Chen M., and Liu H. Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake. J. Microencapsul. 25 (2008) 203-209
133. Zhang X., Pan W., Gan L., Zhu C., Gan Y., and Nie S. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem. Pharm. Bull. (Tokyo) 56 (2008) 1645-1650
134. Zhu R.R., Qin L.L., Wang M., Wu S.M., Wang S.L., Zhang R., Liu Z.X., Sun X.Y., and Yao S.D. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Nanotechnology 20 (2009) 55702